2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Clinical genetics<br />
P01.210<br />
the high frequency <strong>of</strong> new mutations in dystrophin gene in<br />
the group <strong>of</strong> Polish patients affected with Duchenne?Becker<br />
muscular dystrophy<br />
J. G. Zimowski, M. Holding, W. Szirkowiec, E. Fidzianska, J. Kubalska, E.<br />
Zdzienicka, J. Zaremba;<br />
Institute <strong>of</strong> Psychiatry and Neurology, Warsaw, Poland.<br />
The frequency <strong>of</strong> Duchenne/Becker muscular dystrophy (DMD/BMD)<br />
among the newborn males is 1: 3500 . The constant <strong>of</strong> DMD/BMD incidence<br />
in male population is the evidence <strong>of</strong> the stable frequency<br />
<strong>of</strong> new mutations . Although men affected with DMD/BMD usually are<br />
not abble to reproduce incidence <strong>of</strong> the disease remains the same . It<br />
is assumed that 1/3 <strong>of</strong> single DMD/BMD male are the cases <strong>of</strong> new<br />
mutations .<br />
The study <strong>of</strong> carriership was carried out in a group <strong>of</strong> 249 mothers with<br />
one son affected with DMD/BMD in whom deletions in dystrophin gene<br />
were found . The studies <strong>of</strong> microsatellite sequences in the mothers<br />
revealed the presence <strong>of</strong> two different alleles in 138 females, therefore<br />
their carriership could be excluded . In 38 cases, in which mothers or<br />
daughters (sisters <strong>of</strong> affected males) were tested, the presence <strong>of</strong> the<br />
deletion was observed . The homozygozity was detected among 73 females<br />
. Some <strong>of</strong> them may be instances <strong>of</strong> hemizygozity . The exclusion<br />
<strong>of</strong> carriership in 55% <strong>of</strong> tested females is statistically different from the<br />
expected incidence <strong>of</strong> 33% .<br />
Support from State Committee Scientific Research (PBZ-KBN-122/<br />
P05/2004)<br />
P01.211<br />
two novel mutations in a Russian family with X-linked Emery-<br />
Dreifuss muscular dystrophy<br />
A. L. Chuhrova, T. B. Tiburkova, O. A. Schagina, E. L. Dadaly, A. V. Polyakov;<br />
Research centre for medical genetics, Moscow, Russian Federation.<br />
Emery-Dreifuss muscular dystrophy (EDMD) is a neuromuscular<br />
disease characterised by early contractures <strong>of</strong> Achilles-heel, elbows<br />
and spine, slow progression and symmetric weakness prominent in<br />
humero-peroneal muscle, cardiac conduction abnormality and/or cardiomyopathy<br />
and myopathic features . Two main modes <strong>of</strong> inheritance<br />
exist: X-linked and autosomal dominant . The frequency <strong>of</strong> the X-linked<br />
form is at 1:100 000 . EMD gene mutations, which encodes a nuclear<br />
membrane protein named emerin, are causes <strong>of</strong> the X-linked form <strong>of</strong><br />
EDMD . EMD gene has been mapped to the region Xq28 . Mutation<br />
analysis in EMD gene was performed by direct automatic sequence<br />
on Genetic Analyzer 3130 <strong>of</strong> all exons and exon-intron splices . We<br />
describe two novel mutations in the EMD gene in two Russian families<br />
. Mutations change nucleotide sequence <strong>of</strong> the sixth exon in the<br />
EMD gene . Family 1 had a c .664C>T (p .Gln222Stop) which causes a<br />
premature stop-codon at position 222 . In second family we found the<br />
mutation c .449+1delG which causes a disappearance donor spicingsite<br />
and subsequent - a premature stop-codone at position 221 .<br />
P01.212<br />
Genotype-phenotype correlates in autosomal recessive<br />
myotonia congenita<br />
I. Torrente 1 , A. Modoni 2 , E. Pisaneschi 1 , A. D’Amico 2 , L. Merlini 3 , G. Silvestri 2 ,<br />
E. M. Valente 1,4 , B. Dallapiccola 1,5 , M. Lo Monaco 2 ;<br />
1 CSS-Mendel Institute, Rome, Italy, 2 Department <strong>of</strong> Neuroscience, Catholic<br />
University <strong>of</strong> Rome, Rome, Italy, 3 Department <strong>of</strong> Experimental and Diagnostic<br />
Medicine, Division <strong>of</strong> Medical <strong>Genetics</strong>, University <strong>of</strong> Ferrara, Ferrara, Italy,<br />
4 Dpt <strong>of</strong> Medical and Surgical Pediatric Science, University <strong>of</strong> Messina, Messina,<br />
Italy, 5 Department <strong>of</strong> Experimental Medicine and Pathology, “La Sapienza”<br />
University <strong>of</strong> Rome, Rome, Italy.<br />
Myotonia Congenita (MC) is a chloride channel disorder due to mutations<br />
in the CLCN1 gene, inherited in autosomal dominant or recessive<br />
fashion . Beside myotonia <strong>of</strong> variable severity, transitory weakness<br />
(TW) can be detected, especially in recessive cases . Neurophysiologically,<br />
TW corresponds to a transitory depression (TD) <strong>of</strong> the compound<br />
muscle action potential during repetitive nerve stimulation (RNS) . We<br />
sought to correlate specific CLCN1 mutations with both TW and RNSinduced<br />
TD in 28 patients with recessive MC, by adopting a low frequency<br />
RNS protocol (3Hz for 500 stimuli) . The 3Hz RNS induced a<br />
significant TD in 19 patients, all <strong>of</strong> whom experienced variable episodes<br />
<strong>of</strong> TW. Several mutations appeared to correlate with specific<br />
TD patterns . In particular, the homozygous exon 9 deletion, C481X<br />
and IVS1+3A>T mutations (5 cases), as well as the compound heterozygous<br />
mutations G482R and T550R (1 case), always resulted in<br />
marked TD . Conversely, F167L seems to associate with mild or no TD,<br />
since 8 <strong>of</strong> 10 patients carrying this mutation (in compound heterozygosity<br />
with other mutations) had clinical absence <strong>of</strong> TW and a negative<br />
RNS test . Finally, the 3 patients heterozygous for the A531V change<br />
(compound with either R377X or R894X) presented a peculiar pattern<br />
<strong>of</strong> fluctuating TD. This study shows that the 3Hz RNS protocol, well<br />
tolerated by patients, is able to identify distinct neurophysiological TD<br />
patterns correlating with specific CLCN1 mutations. In turn, this may<br />
help understand the molecular basis underlying the phenotypic variability<br />
<strong>of</strong> MC, and may represent a step towards rational therapeutic<br />
strategies .<br />
P01.213<br />
DNA-diagnostics <strong>of</strong> myotonic dystrophy type 1 in Belarus<br />
T. Asadchuk, K. Mosse, N. Rumyantseva;<br />
Scientific-Practical Center “Mother and Child”, Minsk, Belarus.<br />
Myotonic dystrophy type 1 (DM1) is an autosomal dominant, multisystemic<br />
disease, with an estimated incidence <strong>of</strong> 1 in 8000 . DM is caused<br />
by expansion <strong>of</strong> CTG trinucleotide repeats located in the 3´ untranslated<br />
region <strong>of</strong> the myotonin protein kinase (DMPK) gene . The range <strong>of</strong><br />
expansion varies widely from 50 to several thousand repeats . First, we<br />
analysed the distribution <strong>of</strong> CTG-repeats in a cohort <strong>of</strong> normal individuals<br />
from the Belarusian population, and assessed the heterozygosity<br />
and number <strong>of</strong> alleles . PCR-products were analysed by the automated<br />
capillary electrophoresis on the ABI Prism 310 . We found 15 different<br />
allelic variants from 5 up to 28 CTG-repeats . The most common alleles<br />
had 5 repeats (38%) . The heterozygosity <strong>of</strong> the CTG polymorphism <strong>of</strong><br />
the Belarusian population was established as 78% . DNA-diagnostics<br />
<strong>of</strong> DM1 was done in 75 patients from 32 families showing different<br />
symptoms related to the disease . We found small expansions with 70<br />
and 86 CTG repeats in two affected men from two different families .<br />
PCR analysis also shows the high risk <strong>of</strong> mutation <strong>of</strong> the DMPK gene<br />
in 10 patients from 3 families, further confirmed by the Southern blot.<br />
So our PCR-based protocol allows amplification <strong>of</strong> normal-sized alleles<br />
and small expansions . For the large expansion Southern blot<br />
analysis is still the method <strong>of</strong> choice .<br />
P01.214<br />
molecular studies on two myotonic dystrophies (Dm1 and Dm2)<br />
in Polish patients group<br />
W. Krysa1 , A. Sulek-Piatkowska1 , M. Rajkiewicz1 , E. Szmidt-Salkowska2 , A.<br />
Kamińska2 , J. Zaremba1 ;<br />
1 2 Institute <strong>of</strong> Psychiatry and Neurology, Warsaw, Poland, Medical University,<br />
Warsaw, Poland.<br />
Myotonic dystrophies type 1 and type 2 (DM1 and DM2) are autosomal<br />
dominant disorders and share similar symptoms comprising myotonia,<br />
muscular dystrophy, and multisystem involvement (cataracts, diabetes<br />
and hypogonadism), but overall clinical picture <strong>of</strong> these two conditions<br />
is not identical .<br />
Molecular defect causing DM1 and DM2 is known as dynamic mutation<br />
in DMPK and ZNF7 genes respectively . Expansions up to 4000<br />
CTG repeats result in DM1 whereas a CCTG tetramers up to 11000 in<br />
patients with DM2 are observed .<br />
Molecular testing is the only reliable diagnostic definition in DM1 and<br />
DM2 . Prior to its introduction we have performed the analysis <strong>of</strong> normal<br />
alleles distribution in Polish control group . For DM1 locus the range is<br />
5-31 repeats and for DM2 the range <strong>of</strong> repeat motif varied from 123<br />
to 159 bp .<br />
For 5 years 372 individuals were tested for DM1 and/or DM2 by routine<br />
PCR, then all homozygous cases were analyzed by TP-PCR . Among<br />
them we have identified 76 pedigrees with 144 DM1 and 34 pedigrees<br />
with 35 DM2 mutation carriers . Within the group <strong>of</strong> DM1 patients we<br />
identified one family with a case <strong>of</strong> premutation which resulted in full<br />
mutation in the following generation. Moreover, we identified a patient<br />
with a coexistence <strong>of</strong> full mutation and premutation in DMPK gene .<br />
Among DM2 group we came across a family with two patients having<br />
extended alleles - 189 bp and 197 bp i .e . clearly above the normal<br />
range but below the considered as pathogenic range in DM2 (normal<br />
range 104-176 bp) .